Improved Amplification of Genital Human Papillomaviruses

By P. Gravitt, C. Peyton, T. Alessi, C. Wheeler, F. Coutlée, A. Hildesheim, M. Schiffman, David R. Scott, R. Apple. Journal of Clinical Microbiology, 2000

1,165 citations recorded by the source corpus.

Subfields: Epidemiology, Microbiology, Molecular Biology

View Paper: https://www.semanticscholar.org/paper/de2531b4cdbef23adf50f8a354b47ddd6dd82507

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Epidemiology

1. Silvia Franceschi
2. G. Clifford

Citations in the corpus

• Prevalence of HPV infection among females in the United States. (2007, methodology): “This assay uses HPV L1 consensus polymerase chain reaction with biotinylated PGMY09/11 primer sets and -globin as an internal control for sample amplification.(18,19) Five μL of the DNA was used in the 100-μL polymerase chain reaction.”
• Prevalence of Oral HPV Infection in the United States, 2009–2010 (2012, methodology): “Detection of 37 HPV types within the Alphapapillomavirus genera was performed by multiplex polymerase chain reaction (PCR) with PGMY primer pools and primers for -globin followed by line-blot hybridization (Roche Linear Array HPV Genotyping Test; Roche Molecular Systems).(11) Twelve microliters of D”
• Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic Review (2005, positive): “Consensus PCR primers MY09/11 (15), PGMY09/11 (16), GP5+/6+ (17), and SPF10 (18) were considered to amplify the 18 HPV types most commonly associated with cervical cancer (6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 68, 70, 73, 82, and 83; ref.”